Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38819 for Org 36286 (Corifollitropin Alfa)
Brief Summary: The objective of this trial was to evaluate whether Corifollitropin Alfa treatment for the induction of multifollicular growth in women undergoing controlled ovarian stimulation (COS) prior to in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) was safe for pregnant participants and their offspring. The primary endpoint was the take-home baby rate calculated as the number of participants with an ongoing pregnancy in Base Trial P05787 (NCT00696800) with at least one live born infant relative to the number of participants in the Base Trial, and to the number of participants in the Base Trial with Embryo Transfer (ET).


Options:
A: Arm Label: Experimental Group 1; Type: N/A; Interventions: Drug: Org 36286 | Arm Label: Experimental Group 2; Type: N/A; Interventions: Drug: recFSH | Intervention Type: DRUG; Name: Org 36286; Assigned to Arm(s): Experimental Group 1 | Intervention Type: DRUG; Name: recFSH; Assigned to Arm(s): Experimental Group 2
B: Arm Label: Corifollitropin alpha 100 ug; Type: N/A; Interventions: Drug: Corifollitropin alpha (MK-8962, Org 36286) 100 ug, Drug: Triptorelin, Biological: Recombinant follicle stimulating hormone (recFSH), Biological: Human chorionic gonadotprophin (hCG). | Arm Label: Corifollitropin alpha 150 ug; Type: N/A; Interventions: Drug: Corifollitropin alpha (MK-8962, Org 36286) 150 ug, Drug: Triptorelin, Biological: Recombinant follicle stimulating hormone (recFSH), Biological: Human chorionic gonadotprophin (hCG). | Intervention Type: DRUG; Name: Corifollitropin alpha (MK-8962, Org 36286) 100 ug; Assigned to Arm(s): Corifollitropin alpha 100 ug | Intervention Type: DRUG; Name: Corifollitropin alpha (MK-8962, Org 36286) 150 ug; Assigned to Arm(s): Corifollitropin alpha 150 ug | Intervention Type: DRUG; Name: Triptorelin; Assigned to Arm(s): Corifollitropin alpha 100 ug, Corifollitropin alpha 150 ug | Intervention Type: BIOLOGICAL; Name: Recombinant follicle stimulating hormone (recFSH); Assigned to Arm(s): Corifollitropin alpha 100 ug, Corifollitropin alpha 150 ug | Intervention Type: BIOLOGICAL; Name: Human chorionic gonadotprophin (hCG).; Assigned to Arm(s): Corifollitropin alpha 100 ug, Corifollitropin alpha 150 ug
C: Arm Label: Mothers Corifollitropin Alfa 150 µg; Type: N/A; Interventions: Drug: Corifollitropin Alfa 150 μg, Drug: Placebo for RecFSH/Follitropin beta, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: Mothers recFSH 200 IU; Type: N/A; Interventions: Biological: 200 IU RecFSH/Follitropin beta (Days 1 to 7), Drug: Placebo for Corifollitropin Alfa, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin Alfa 150 μg; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 1 to 7); Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for Corifollitropin Alfa; Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for RecFSH/Follitropin beta; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 8 to hCG); Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU
D: Arm Label: 150 µg Corifollitropin Alfa; Type: EXPERIMENTAL; Interventions: Drug: Corifollitropin alfa, Drug: Placebo RecFSH / follitropin beta, Biological: RecFSH / Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: 200 IU recFSH; Type: ACTIVE_COMPARATOR; Interventions: Biological: RecFSH / Follitropin beta (Days 1 to 7), Drug: Placebo Corifollitropin alfa, Biological: RecFSH / Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: RecFSH / Follitropin beta (Days 1 to 7); Assigned to Arm(s): 200 IU recFSH | Intervention Type: DRUG; Name: Placebo Corifollitropin alfa; Assigned to Arm(s): 200 IU recFSH | Intervention Type: DRUG; Name: Placebo RecFSH / follitropin beta; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: RecFSH / Follitropin beta (Days 8 to hCG); Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH

Answer: C